326 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
Rank Status Study
21 Recruiting Effect of Camel Milk on Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon, Ribavirin, camel milk;   Drug: Peginterferon, Ribavirin
22 Recruiting Study of Oral Treatments for Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: sofosbuvir/ledipasvir;   Drug: ombitasvir/paritaprevir/ritonavir;   Drug: elbasvir/grazoprevir;   Drug: Dasabuvir
23 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
24 Unknown  Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
Conditions: Chronic Hepatitis c;   Insulin Resistance
Interventions: Drug: metformin;   Drug: pegylated-IFN;   Drug: ribavirin
25 Unknown  The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients
Condition: Hepatitis C
Intervention: Biological: Peginterferon lambda
26 Unknown  Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments
Condition: Chronic Hepatitis C
Intervention:
27 Recruiting Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
Condition: Chronic Hepatitis C Virus
Intervention:
28 Unknown  Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?
Condition: Chronic Hepatitis C
Interventions: Drug: Peg + Vitamin D + Ribavirin;   Drug: Peg + Ribavirin
29 Recruiting Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C Infection
Intervention:
30 Unknown  Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C
Intervention: Dietary Supplement: Vit D
31 Recruiting BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: BIP 48 (Peginterferon alfa 2b 48kDA);   Drug: Peginterferon alfa 2a 40kDA
32 Recruiting Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Chlorcyclizine HCL plus Ribavirin;   Drug: Chlorcyclizine HCL Only
33 Unknown  Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Reiferon retard
34 Recruiting Effectiveness of Paritaprevir/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania
Condition: Chronic Hepatitis C
Intervention:
35 Recruiting Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada
Condition: Chronic Hepatitis C
Intervention:
36 Not yet recruiting Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) or AL-335 and ODV in the Treatment of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: AL-335;   Drug: Odalasvir;   Drug: Simeprevir
37 Unknown  PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
Condition: Chronic Hepatitis C
Intervention: Drug: Peginterferon alfa-2a and Ribavirin
38 Recruiting Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Condition: Chronic Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: GS-5816
39 Recruiting Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)
Condition: Chronic Hepatitis C
Intervention:
40 Unknown  A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Celgosivir;   Drug: Peginterferon alfa 2b + ribavirin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years